Global Oncology Drugs Market Growth (Status and Outlook) 2021-2026

Global Oncology Drugs Market Growth (Status and Outlook) 2021-2026

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Oncology Drugs Market Size 2016-2026
2.1.2 Oncology Drugs Market Size CAGR by Region 2020 VS 2021 VS 2026
2.2 Oncology Drugs Segment by Type
2.2.1 Chemotherapy
2.2.2 Chemotherapy
2.2.3 Immunotherapy (Biologic Therapy)
2.2.4 Hormonal Therapy
2.2.5 Others
2.3 Oncology Drugs Market Size by Type
2.3.1 Global Oncology Drugs Market Size CAGR by Type
2.3.2 Global Oncology Drugs Market Size Market Share by Type (2016-2021)
2.4 Oncology Drugs Segment by Application
2.4.1 Blood Cancer
2.4.2 Breast Cancer
2.4.3 Gastrointestinal Cancer
2.4.4 Prostate Cancer
2.4.5 Respiratory or Lung Cancer
2.4.6 Others
2.5 Oncology Drugs Market Size by Application
2.5.1 Global Oncology Drugs Market Size CAGR by Application
2.5.2 Global Oncology Drugs Market Size Market Share by Application (2016-2021)

3 Oncology Drugs Market Size by Players
3.1 Oncology Drugs Market Size Market Share by Players
3.1.1 Global Oncology Drugs Revenue by Players (2019-2021E)
3.1.2 Global Oncology Drugs Revenue Market Share by Players (2019-2021E)
3.2 Global Oncology Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2019-2021E)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 Oncology Drugs by Regions
4.1 Oncology Drugs Market Size by Regions (2016-2021)
4.2 Americas Oncology Drugs Market Size Growth (2016-2021)
4.3 APAC Oncology Drugs Market Size Growth (2016-2021)
4.4 Europe Oncology Drugs Market Size Growth (2016-2021)
4.5 Middle East & Africa Oncology Drugs Market Size Growth (2016-2021)

5 Americas
5.1 Americas Oncology Drugs Market Size by Country (2016-2021)
5.2 Americas Oncology Drugs Market Size by Type (2016-2021)
5.3 Americas Oncology Drugs Market Size by Application (2016-2021)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC
6.1 APAC Oncology Drugs Market Size by Region (2016-2021)
6.2 APAC Oncology Drugs Market Size by Type (2016-2021)
6.3 APAC Oncology Drugs Market Size by Application (2016-2021)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 Europe
7.1 Europe Oncology Drugs by Country (2016-2021)
7.2 Europe Oncology Drugs Market Size by Type (2016-2021)
7.3 Europe Oncology Drugs Market Size by Application (2016-2021)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 Middle East & Africa
8.1 Middle East & Africa Oncology Drugs by Region (2016-2021)
8.2 Middle East & Africa Oncology Drugs Market Size by Type (2016-2021)
8.3 Middle East & Africa Oncology Drugs Market Size by Application (2016-2021)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Global Oncology Drugs Market Forecast
10.1 Global Oncology Drugs Forecast by Regions (2021-2026)
10.1.1 Global Oncology Drugs Forecast by Regions (2021-2026)
10.1.2 Americas Oncology Drugs Forecast
10.1.3 APAC Oncology Drugs Forecast
10.1.4 Europe Oncology Drugs Forecast
10.1.5 Middle East & Africa Oncology Drugs Forecast
10.2 Americas Oncology Drugs Forecast by Countries (2021-2026)
10.2.1 United States Oncology Drugs Market Forecast
10.2.2 Canada Oncology Drugs Market Forecast
10.2.3 Mexico Oncology Drugs Market Forecast
10.2.4 Brazil Oncology Drugs Market Forecast
10.3 APAC Oncology Drugs Forecast by Region (2021-2026)
10.3.1 China Oncology Drugs Market Forecast
10.3.2 Japan Oncology Drugs Market Forecast
10.3.3 Korea Oncology Drugs Market Forecast
10.3.4 Southeast Asia Oncology Drugs Market Forecast
10.3.5 India Oncology Drugs Market Forecast
10.3.6 Australia Oncology Drugs Market Forecast
10.4 Europe Oncology Drugs Forecast by Country (2021-2026)
10.4.1 Germany Oncology Drugs Market Forecast
10.4.2 France Oncology Drugs Market Forecast
10.4.3 UK Oncology Drugs Market Forecast
10.4.4 Italy Oncology Drugs Market Forecast
10.4.5 Russia Oncology Drugs Market Forecast
10.5 Middle East & Africa Oncology Drugs Forecast by Region (2021-2026)
10.5.1 Egypt Oncology Drugs Market Forecast
10.5.2 South Africa Oncology Drugs Market Forecast
10.5.3 Israel Oncology Drugs Market Forecast
10.5.4 Turkey Oncology Drugs Market Forecast
10.5.5 GCC Countries Oncology Drugs Market Forecast
10.6 Global Oncology Drugs Forecast by Type (2021-2026)
10.7 Global Oncology Drugs Forecast by Application (2021-2026)

11 Key Players Analysis
11.1 Roche
11.1.1 Roche Company Information
11.1.2 Roche Oncology Drugs Product Offered
11.1.3 Roche Oncology Drugs Revenue, Gross Margin and Market Share (2019-2021)
11.1.4 Roche Main Business Overview
11.1.5 Roche Latest Developments
11.2 Celgene
11.2.1 Celgene Company Information
11.2.2 Celgene Oncology Drugs Product Offered
11.2.3 Celgene Oncology Drugs Revenue, Gross Margin and Market Share (2019-2021)
11.2.4 Celgene Main Business Overview
11.2.5 Celgene Latest Developments
11.3 Novartis
11.3.1 Novartis Company Information
11.3.2 Novartis Oncology Drugs Product Offered
11.3.3 Novartis Oncology Drugs Revenue, Gross Margin and Market Share (2019-2021)
11.3.4 Novartis Main Business Overview
11.3.5 Novartis Latest Developments
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Information
11.4.2 Bristol-Myers Squibb Oncology Drugs Product Offered
11.4.3 Bristol-Myers Squibb Oncology Drugs Revenue, Gross Margin and Market Share (2019-2021)
11.4.4 Bristol-Myers Squibb Main Business Overview
11.4.5 Bristol-Myers Squibb Latest Developments
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Company Information
11.5.2 Johnson & Johnson Oncology Drugs Product Offered
11.5.3 Johnson & Johnson Oncology Drugs Revenue, Gross Margin and Market Share (2019-2021)
11.5.4 Johnson & Johnson Main Business Overview
11.5.5 Johnson & Johnson Latest Developments
11.6 Merck & Co.
11.6.1 Merck & Co. Company Information
11.6.2 Merck & Co. Oncology Drugs Product Offered
11.6.3 Merck & Co. Oncology Drugs Revenue, Gross Margin and Market Share (2019-2021)
11.6.4 Merck & Co. Main Business Overview
11.6.5 Merck & Co. Latest Developments
11.7 AstraZeneca
11.7.1 AstraZeneca Company Information
11.7.2 AstraZeneca Oncology Drugs Product Offered
11.7.3 AstraZeneca Oncology Drugs Revenue, Gross Margin and Market Share (2019-2021)
11.7.4 AstraZeneca Main Business Overview
11.7.5 AstraZeneca Latest Developments
11.8 Pfizer
11.8.1 Pfizer Company Information
11.8.2 Pfizer Oncology Drugs Product Offered
11.8.3 Pfizer Oncology Drugs Revenue, Gross Margin and Market Share (2019-2021)
11.8.4 Pfizer Main Business Overview
11.8.5 Pfizer Latest Developments
11.9 Amgen
11.9.1 Amgen Company Information
11.9.2 Amgen Oncology Drugs Product Offered
11.9.3 Amgen Oncology Drugs Revenue, Gross Margin and Market Share (2019-2021)
11.9.4 Amgen Main Business Overview
11.9.5 Amgen Latest Developments
11.10 Eli Lilly
11.10.1 Eli Lilly Company Information
11.10.2 Eli Lilly Oncology Drugs Product Offered
11.10.3 Eli Lilly Oncology Drugs Revenue, Gross Margin and Market Share (2019-2021)
11.10.4 Eli Lilly Main Business Overview
11.10.5 Eli Lilly Latest Developments
11. AbbVie
11.11.1 AbbVie Company Information
11.11.2 AbbVie Oncology Drugs Product Offered
11.11.3 AbbVie Oncology Drugs Revenue, Gross Margin and Market Share (2019-2021)
11.11.4 AbbVie Main Business Overview
11.11.5 AbbVie Latest Developments
11.12 Takeda
11.12.1 Takeda Company Information
11.12.2 Takeda Oncology Drugs Product Offered
11.12.3 Takeda Oncology Drugs Revenue, Gross Margin and Market Share (2019-2021)
11.12.4 Takeda Main Business Overview
11.12.5 Takeda Latest Developments
11.13 Astellas
11.13.1 Astellas Company Information
11.13.2 Astellas Oncology Drugs Product Offered
11.13.3 Astellas Oncology Drugs Revenue, Gross Margin and Market Share (2019-2021)
11.13.4 Astellas Main Business Overview
11.13.5 Astellas Latest Developments
11.14 Ipsen
11.14.1 Ipsen Company Information
11.14.2 Ipsen Oncology Drugs Product Offered
11.14.3 Ipsen Oncology Drugs Revenue, Gross Margin and Market Share (2019-2021)
11.14.4 Ipsen Main Business Overview
11.14.5 Ipsen Latest Developments
11.15 Sanofi
11.15.1 Sanofi Company Information
11.15.2 Sanofi Oncology Drugs Product Offered
11.15.3 Sanofi Oncology Drugs Revenue, Gross Margin and Market Share (2019-2021)
11.15.4 Sanofi Main Business Overview
11.15.5 Sanofi Latest Developments
11.16 Bayer
11.16.1 Bayer Company Information
11.16.2 Bayer Oncology Drugs Product Offered
11.16.3 Bayer Oncology Drugs Revenue, Gross Margin and Market Share (2019-2021)
11.16.4 Bayer Main Business Overview
11.16.5 Bayer Latest Developments
11.17 Biogen Idec
11.17.1 Biogen Idec Company Information
11.17.2 Biogen Idec Oncology Drugs Product Offered
11.17.3 Biogen Idec Oncology Drugs Revenue, Gross Margin and Market Share (2019-2021)
11.17.4 Biogen Idec Main Business Overview
11.17.5 Biogen Idec Latest Developments
11.18 Teva
11.18.1 Teva Company Information
11.18.2 Teva Oncology Drugs Product Offered
11.18.3 Teva Oncology Drugs Revenue, Gross Margin and Market Share (2019-2021)
11.18.4 Teva Main Business Overview
11.18.5 Teva Latest Developments
11.19 Otsuka
11.19.1 Otsuka Company Information
11.19.2 Otsuka Oncology Drugs Product Offered
11.19.3 Otsuka Oncology Drugs Revenue, Gross Margin and Market Share (2019-2021)
11.19.4 Otsuka Main Business Overview
11.19.5 Otsuka Latest Developments
11.20 Eisai
11.20.1 Eisai Company Information
11.20.2 Eisai Oncology Drugs Product Offered
11.20.3 Eisai Oncology Drugs Revenue, Gross Margin and Market Share (2019-2021)
11.20.4 Eisai Main Business Overview
11.20.5 Eisai Latest Developments
11.21 Merck KGaA
11.21.1 Merck KGaA Company Information
11.21.2 Merck KGaA Oncology Drugs Product Offered
11.21.3 Merck KGaA Oncology Drugs Revenue, Gross Margin and Market Share (2019-2021)
11.21.4 Merck KGaA Main Business Overview
11.21.5 Merck KGaA Latest Developments
11.22 Gilead Sciences
11.22.1 Gilead Sciences Company Information
11.22.2 Gilead Sciences Oncology Drugs Product Offered
11.22.3 Gilead Sciences Oncology Drugs Revenue, Gross Margin and Market Share (2019-2021)
11.22.4 Gilead Sciences Main Business Overview
11.22.5 Gilead Sciences Latest Developments

12 Research Findings and Conclusion

List of Tables
Table 1. Oncology Drugs Market Size CAGR by Region (2020-2026) & ($ Millions)
Table 2. Major Players of Chemotherapy
Table 3. Major Players of Targeted Therapy
Table 4. Major Players of Immunotherapy (Biologic Therapy)
Table 5. Major Players of Hormonal Therapy
Table 6. Major Players of Others
Table 7. Oncology Drugs Market Size CAGR by Type (2020-2026) & ($ Millions)
Table 8. Global Oncology Drugs Market Size by Type (2016-2021) & ($ Millions)
Table 9. Global Oncology Drugs Market Size Market Share by Type (2016-2021)
Table 10. Oncology Drugs Market Size CAGR by Application (2016-2021) & ($ Millions)
Table 11. Global Oncology Drugs Market Size by Application (2016-2021) & ($ Millions)
Table 12. Global Oncology Drugs Market Size Market Share by Application (2016-2021)
Table 13. Global Oncology Drugs Revenue by Players (2019-2021E) & ($ Millions)
Table 14. Global Oncology Drugs Revenue Market Share by Players (2019-2021E)
Table 15. Oncology Drugs Key Players Head office and Products Offered
Table 16. Oncology Drugs Concentration Ratio (CR3, CR5 and CR10) & (2019-2021E)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Oncology Drugs Market Size by Regions 2016-2021 & ($ Millions)
Table 20. Global Oncology Drugs Market Size Market Share by Regions 2016-2021
Table 21. Americas Oncology Drugs Market Size by Country (2016-2021) & ($ Millions)
Table 22. Americas Oncology Drugs Market Size Market Share by Country (2016-2021)
Table 23. Americas Oncology Drugs Market Size by Type (2016-2021) & ($ Millions)
Table 24. Americas Oncology Drugs Market Size Market Share by Type (2016-2021)
Table 25. Americas Oncology Drugs Market Size by Application (2016-2021) & ($ Millions)
Table 26. Americas Oncology Drugs Market Size Market Share by Application (2016-2021)
Table 27. APAC Oncology Drugs Market Size by Region (2016-2021) & ($ Millions)
Table 28. APAC Oncology Drugs Market Size Market Share by Region (2016-2021)
Table 29. APAC Oncology Drugs Market Size by Type (2016-2021) & ($ Millions)
Table 30. APAC Oncology Drugs Market Size Market Share by Type (2016-2021)
Table 31. APAC Oncology Drugs Market Size by Application (2016-2021) & ($ Millions)
Table 32. APAC Oncology Drugs Market Size Market Share by Application (2016-2021)
Table 33. Europe Oncology Drugs Market Size by Country (2016-2021) & ($ Millions)
Table 34. Europe Oncology Drugs Market Size Market Share by Country (2016-2021)
Table 35. Europe Oncology Drugs Market Size by Type (2016-2021) & ($ Millions)
Table 36. Europe Oncology Drugs Market Size Market Share by Type (2016-2021)
Table 37. Europe Oncology Drugs Market Size by Application (2016-2021) & ($ Millions)
Table 38. Europe Oncology Drugs Market Size Market Share by Application (2016-2021)
Table 39. Middle East & Africa Oncology Drugs Market Size by Region (2016-2021) & ($ Millions)
Table 40. Middle East & Africa Oncology Drugs Market Size Market Share by Region (2016-2021)
Table 41. Middle East & Africa Oncology Drugs Market Size by Type (2016-2021) & ($ Millions)
Table 42. Middle East & Africa Oncology Drugs Market Size Market Share by Type (2016-2021)
Table 43. Middle East & Africa Oncology Drugs Market Size by Application (2016-2021) & ($ Millions)
Table 44. Middle East & Africa Oncology Drugs Market Size Market Share by Application (2016-2021)
Table 45. Key and Potential Regions of Oncology Drugs
Table 46. Key Application and Potential Industries of Oncology Drugs
Table 47. Key Challenges of Oncology Drugs
Table 48. Key Trends of Oncology Drugs
Table 49. Global Oncology Drugs Market Size Forecast by Regions (2021-2026) & ($ Millions)
Table 50. Global Oncology Drugs Market Size Market Share Forecast by Regions (2021-2026)
Table 51. Global Oncology Drugs Market Size Forecast by Type (2021-2026) & ($ Millions)
Table 52. Global Oncology Drugs Market Size Market Share Forecast by Type (2021-2026)
Table 53. Global Oncology Drugs Market Size Forecast by Application (2021-2026) & ($ Millions)
Table 54. Global Oncology Drugs Market Size Market Share Forecast by Application (2021-2026)
Table 55. Roche Details, Company Type, Oncology Drugs Area Served and Its Competitors
Table 56. Roche Oncology Drugs Product Offered
Table 57. Roche Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 58. Roche Main Business
Table 59. Roche Latest Developments
Table 60. Celgene Details, Company Type, Oncology Drugs Area Served and Its Competitors
Table 61. Celgene Oncology Drugs Product Offered
Table 62. Celgene Main Business
Table 63. Celgene Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 64. Celgene Latest Developments
Table 65. Novartis Details, Company Type, Oncology Drugs Area Served and Its Competitors
Table 66. Novartis Oncology Drugs Product Offered
Table 67. Novartis Main Business
Table 68. Novartis Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 69. Novartis Latest Developments
Table 70. Bristol-Myers Squibb Details, Company Type, Oncology Drugs Area Served and Its Competitors
Table 71. Bristol-Myers Squibb Oncology Drugs Product Offered
Table 72. Bristol-Myers Squibb Main Business
Table 73. Bristol-Myers Squibb Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 74. Bristol-Myers Squibb Latest Developments
Table 75. Johnson & Johnson Details, Company Type, Oncology Drugs Area Served and Its Competitors
Table 76. Johnson & Johnson Oncology Drugs Product Offered
Table 77. Johnson & Johnson Main Business
Table 78. Johnson & Johnson Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 79. Johnson & Johnson Latest Developments
Table 80. Merck & Co. Details, Company Type, Oncology Drugs Area Served and Its Competitors
Table 81. Merck & Co. Oncology Drugs Product Offered
Table 82. Merck & Co. Main Business
Table 83. Merck & Co. Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 84. Merck & Co. Latest Developments
Table 85. AstraZeneca Details, Company Type, Oncology Drugs Area Served and Its Competitors
Table 86. AstraZeneca Oncology Drugs Product Offered
Table 87. AstraZeneca Main Business
Table 88. AstraZeneca Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 89. AstraZeneca Latest Developments
Table 90. Pfizer Details, Company Type, Oncology Drugs Area Served and Its Competitors
Table 91. Pfizer Oncology Drugs Product Offered
Table 92. Pfizer Main Business
Table 93. Pfizer Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 94. Pfizer Latest Developments
Table 95. Amgen Details, Company Type, Oncology Drugs Area Served and Its Competitors
Table 96. Amgen Oncology Drugs Product Offered
Table 97. Amgen Main Business
Table 98. Amgen Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 99. Amgen Latest Developments
Table 100. Eli Lilly Details, Company Type, Oncology Drugs Area Served and Its Competitors
Table 101. Eli Lilly Oncology Drugs Product Offered
Table 102. Eli Lilly Main Business
Table 103. Eli Lilly Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 104. Eli Lilly Latest Developments
Table 105. AbbVie Details, Company Type, Oncology Drugs Area Served and Its Competitors
Table 106. AbbVie Oncology Drugs Product Offered
Table 107. AbbVie Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 108. AbbVie Main Business
Table 109. AbbVie Latest Developments
Table 110. Takeda Details, Company Type, Oncology Drugs Area Served and Its Competitors
Table 111. Takeda Oncology Drugs Product Offered
Table 112. Takeda Main Business
Table 113. Takeda Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 114. Takeda Latest Developments
Table 115. Astellas Details, Company Type, Oncology Drugs Area Served and Its Competitors
Table 116. Astellas Oncology Drugs Product Offered
Table 117. Astellas Main Business
Table 118. Astellas Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 119. Astellas Latest Developments
Table 120. Ipsen Details, Company Type, Oncology Drugs Area Served and Its Competitors
Table 121. Ipsen Oncology Drugs Product Offered
Table 122. Ipsen Main Business
Table 123. Ipsen Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 124. Ipsen Latest Developments
Table 125. Sanofi Details, Company Type, Oncology Drugs Area Served and Its Competitors
Table 126. Sanofi Oncology Drugs Product Offered
Table 127. Sanofi Main Business
Table 128. Sanofi Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 129. Sanofi Latest Developments
Table 130. Bayer Details, Company Type, Oncology Drugs Area Served and Its Competitors
Table 131. Bayer Oncology Drugs Product Offered
Table 132. Bayer Main Business
Table 133. Bayer Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 134. Bayer Latest Developments
Table 135. Biogen Idec Details, Company Type, Oncology Drugs Area Served and Its Competitors
Table 136. Biogen Idec Oncology Drugs Product Offered
Table 137. Biogen Idec Main Business
Table 138. Biogen Idec Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 139. Biogen Idec Latest Developments
Table 140. Teva Details, Company Type, Oncology Drugs Area Served and Its Competitors
Table 141. Teva Oncology Drugs Product Offered
Table 142. Teva Main Business
Table 143. Teva Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 144. Teva Latest Developments
Table 145. Otsuka Details, Company Type, Oncology Drugs Area Served and Its Competitors
Table 146. Otsuka Oncology Drugs Product Offered
Table 147. Otsuka Main Business
Table 148. Otsuka Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 149. Otsuka Latest Developments
Table 150. Eisai Details, Company Type, Oncology Drugs Area Served and Its Competitors
Table 151. Eisai Oncology Drugs Product Offered
Table 152. Eisai Main Business
Table 153. Eisai Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 154. Eisai Latest Developments
Table 155. Merck KGaA Details, Company Type, Oncology Drugs Area Served and Its Competitors
Table 156. Merck KGaA Oncology Drugs Product Offered
Table 157. Merck KGaA Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 158. Merck KGaA Main Business
Table 159. Merck KGaA Latest Developments
Table 160. Gilead Sciences Details, Company Type, Oncology Drugs Area Served and Its Competitors
Table 161. Gilead Sciences Oncology Drugs Product Offered
Table 162. Gilead Sciences Main Business
Table 163. Gilead Sciences Oncology Drugs Revenue ($ million), Gross Margin and Market Share (2019-2021E)
Table 164. Gilead Sciences Latest Developments
List of Figures
Figure 1. Oncology Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Oncology Drugs Market Size Growth Rate 2016-2026 ($ Millions)
Figure 6. Global Oncology Drugs Market Size Market Share by Type in 2020
Figure 7. Oncology Drugs in Blood Cancer
Figure 8. Global Oncology Drugs Market: Blood Cancer (2016-2021) & ($ Millions)
Figure 9. Oncology Drugs in Breast Cancer
Figure 10. Global Oncology Drugs Market: Breast Cancer (2016-2021) & ($ Millions)
Figure 11. Oncology Drugs in Gastrointestinal Cancer
Figure 12. Global Oncology Drugs Market: Gastrointestinal Cancer (2016-2021) & ($ Millions)
Figure 13. Oncology Drugs in Prostate Cancer
Figure 14. Global Oncology Drugs Market: Prostate Cancer (2016-2021) & ($ Millions)
Figure 15. Oncology Drugs in Respiratory or Lung Cancer
Figure 16. Global Oncology Drugs Market: Respiratory or Lung Cancer (2016-2021) & ($ Millions)
Figure 17. Oncology Drugs in Others
Figure 18. Global Oncology Drugs Market: Others (2016-2021) & ($ Millions)
Figure 19. Global Oncology Drugs Market Size Market Share by Application in 2020
Figure 20. Global Oncology Drugs Revenue Market Share by Player in 2020
Figure 21. Global Oncology Drugs Market Size Market Share by Regions (2016-2021)
Figure 22. Americas Oncology Drugs Market Size 2016-2021 ($ Millions)
Figure 23. APAC Oncology Drugs Market Size 2016-2021 ($ Millions)
Figure 24. Europe Oncology Drugs Market Size 2016-2021 ($ Millions)
Figure 25. Middle East & Africa Oncology Drugs Market Size 2016-2021 ($ Millions)
Figure 26. Americas Oncology Drugs Market Size Market Share by Country in 2020
Figure 27. Americas Oncology Drugs Market Size Market Share by Type in 2020
Figure 28. Americas Oncology Drugs Market Size Market Share by Application in 2020
Figure 29. United States Oncology Drugs Market Size Growth 2016-2021 ($ Millions)
Figure 30. Canada Oncology Drugs Market Size Growth 2016-2021 ($ Millions)
Figure 31. Mexico Oncology Drugs Market Size Growth 2016-2021 ($ Millions)
Figure 32. APAC Oncology Drugs Market Size Market Share by Regions in 2020
Figure 33. APAC Oncology Drugs Market Size Market Share by Type in 2020
Figure 34. APAC Oncology Drugs Market Size Market Share by Application in 2020
Figure 35. China Oncology Drugs Market Size Growth 2016-2021 ($ Millions)
Figure 36. Japan Oncology Drugs Market Size Growth 2016-2021 ($ Millions)
Figure 37. Korea Oncology Drugs Market Size Growth 2016-2021 ($ Millions)
Figure 38. Southeast Asia Oncology Drugs Market Size Growth 2016-2021 ($ Millions)
Figure 39. India Oncology Drugs Market Size Growth 2016-2021 ($ Millions)
Figure 40. Australia Oncology Drugs Market Size Growth 2016-2021 ($ Millions)
Figure 41. Europe Oncology Drugs Market Size Market Share by Country in 2020
Figure 42. Europe Oncology Drugs Market Size Market Share by Type in 2020
Figure 43. Europe Oncology Drugs Market Size Market Share by Application in 2020
Figure 44. Germany Oncology Drugs Market Size Growth 2016-2021 ($ Millions)
Figure 45. France Oncology Drugs Market Size Growth 2016-2021 ($ Millions)
Figure 46. UK Oncology Drugs Market Size Growth 2016-2021 ($ Millions)
Figure 47. Italy Oncology Drugs Market Size Growth 2016-2021 ($ Millions)
Figure 48. Russia Oncology Drugs Market Size Growth 2016-2021 ($ Millions)
Figure 49. Middle East & Africa Oncology Drugs Market Size Market Share by Region in 2020
Figure 50. Middle East & Africa Oncology Drugs Market Size Market Share by Type in 2020
Figure 51. Middle East & Africa Oncology Drugs Market Size Market Share by Application in 2020
Figure 52. Egypt Oncology Drugs Market Size Growth 2016-2021 ($ Millions)
Figure 53. South Africa Oncology Drugs Market Size Growth 2016-2021 ($ Millions)
Figure 54. Israel Oncology Drugs Market Size Growth 2016-2021 ($ Millions)
Figure 55. Turkey Oncology Drugs Market Size Growth 2016-2021 ($ Millions)
Figure 56. GCC Country Oncology Drugs Market Size Growth 2016-2021 ($ Millions)
Figure 57. Americas Oncology Drugs Market Size 2021-2026 ($ Millions)
Figure 58. APAC Oncology Drugs Market Size 2021-2026 ($ Millions)
Figure 59. Europe Oncology Drugs Market Size 2021-2026 ($ Millions)
Figure 60. Middle East & Africa Oncology Drugs Market Size 2021-2026 ($ Millions)
Figure 61. United States Oncology Drugs Market Size 2021-2026 ($ Millions)
Figure 62. Canada Oncology Drugs Market Size 2021-2026 ($ Millions)
Figure 63. Mexico Oncology Drugs Market Size 2021-2026 ($ Millions)
Figure 64. Brazil Oncology Drugs Market Size 2021-2026 ($ Millions)
Figure 65. China Oncology Drugs Market Size 2021-2026 ($ Millions)
Figure 66. Japan Oncology Drugs Market Size 2021-2026 ($ Millions)
Figure 67. Korea Oncology Drugs Market Size 2021-2026 ($ Millions)
Figure 68. Southeast Asia Oncology Drugs Market Size 2021-2026 ($ Millions)
Figure 69. India Oncology Drugs Market Size 2021-2026 ($ Millions)
Figure 70. Australia Oncology Drugs Market Size 2021-2026 ($ Millions)
Figure 71. Germany Oncology Drugs Market Size 2021-2026 ($ Millions)
Figure 72. France Oncology Drugs Market Size 2021-2026 ($ Millions)
Figure 73. UK Oncology Drugs Market Size 2021-2026 ($ Millions)
Figure 74. Italy Oncology Drugs Market Size 2021-2026 ($ Millions)
Figure 75. Russia Oncology Drugs Market Size 2021-2026 ($ Millions)
Figure 76. Spain Oncology Drugs Market Size 2021-2026 ($ Millions)
Figure 77. Egypt Oncology Drugs Market Size 2021-2026 ($ Millions)
Figure 78. South Africa Oncology Drugs Market Size 2021-2026 ($ Millions)
Figure 79. Israel Oncology Drugs Market Size 2021-2026 ($ Millions)
Figure 80. Turkey Oncology Drugs Market Size 2021-2026 ($ Millions)
Figure 81. GCC Country Oncology Drugs Market Size 2021-2026 ($ Millions)

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global 5-Fluorouracil Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 76

The global 5-Fluorouracil market was valued at US$ 283 million in 2023 and is anticipated to reach US$ 487.9 million by 2030, witnessing a CAGR of 4.3% during The forecast period 2024-2030. North American market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by ......

Global Carboplatin Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global Carboplatin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % d......

Global Neutropenia Drugs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 96

The global Neutropenia Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated to increa......

Global Small Molecule Cancer Drug Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Small Molecule Cancer Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated ......

Global Capecitabine Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 80

Capecitabine is an orally-administered chemotherapeutic agent used in The treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in The tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. Common side effects include abdominal pain, vomiting, diarrhea, weakness, and rashes. Other severe side effects include blood clotting problems, allergic reactions, heart problems, and low blo......

Global Oxaliplatin Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 104

Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy The third stage colon cancer after resecting primary tumor completely. In this report, only The finished drug is covered, exclude API. The global Oxaliplatin market was valued at US$ 897.5 million in 2023 and is anticipated to reach US$ 1641.5 million by 2030, witnessing a CAGR of 8.9% duri......

Global Cancer Treatment Drugs Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 158

According to our LPI (LP Information) latest study, the global Cancer Treatment Drugs market size was valued at US$ 174990 million in 2023. With growing demand in downstream market, the Cancer Treatment Drugs is forecast to a readjusted size of US$ 322540 million by 2030 with a CAGR of 9.1% during review period. The research report highlights the growth potential of the global Cancer Treatment Drugs market. Cancer Treatment Drugs are expected to show stable growth in the future market. H......

Global Capecitabine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 93

According to our LPI (LP Information) latest study, the global Capecitabine market size was valued at US$ 1003.9 million in 2023. With growing demand in downstream market, the Capecitabine is forecast to a readjusted size of US$ 975.1 million by 2030 with a CAGR of -0.4% during review period. The research report highlights the growth potential of the global Capecitabine market. Capecitabine are expected to show stable growth in the future market. However, product differentiation, reducin......

Global Methotrexate Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95

According to our LPI (LP Information) latest study, the global Methotrexate market size was valued at US$ 506 million in 2023. With growing demand in downstream market, the Methotrexate is forecast to a readjusted size of US$ 613.9 million by 2030 with a CAGR of 2.8% during review period. The research report highlights the growth potential of the global Methotrexate market. Methotrexate are expected to show stable growth in the future market. However, product differentiation, reducing co......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs